[FATE] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
07-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -23.29%
YoY- -39.79%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 2,802 2,429 2,817 2,632 1,661 1,026 1,027 94.89%
PBT -28,302 -26,609 -23,478 -19,760 -16,027 -16,782 -19,654 27.43%
Tax 691 910 1,015 1,091 817 339 376 49.86%
NP -28,302 -26,609 -23,478 -19,760 -16,027 -16,782 -19,654 27.43%
Tax Rate - - - - - - - -
Total Cost 31,104 29,038 26,295 22,392 17,688 17,808 20,681 31.17%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -1,010.06 -1,095.47 -833.44 -750.76 -964.90 -1,635.67 -1,913.73 -34.61%
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -0.37 -0.40 -0.36 -0.30 -0.25 -0.31 -0.37 0.00%
EPS Diluted -0.37 -0.40 -0.36 -0.30 -0.25 -0.31 -0.37 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.